BioTurku company licenses biomaterial technology to Bayer

BioTurku company licenses biomaterial technology to BayerTurku Science Park -based DelSiTech Ltd and Bayer Innovation GmbH (Düsseldorf, Germany) have announced that they have entered into a license agreement. The agreement enables Bayer the exclusive rights to use the unique and proprietary DelSiTech ® drug delivery technology for fiber applications in the fields of wound care and certain other applications.

Under the terms of the agreement DelSiTech will receive a signing fee, milestone payments and further royalties for future sales of the products using the DelSiTech technology. The agreement contains also an option for further collaboration.

The full pressrelease